BioCentury | Nov 12, 2009
Distillery Therapeutics

Indication: Neurology

...2009 Multiple patent applications filed and two patents issued; all patents and applications licensed by InterveXion Therapeutics LLC...
BioCentury | Jun 13, 2005
Company News

InterveXion, Medicago deal

...to produce clinical supplies of a monoclonal antibody from InterveXion to treat phencyclidine (PCP) addiction. InterveXion...
...million grant from the NIH's National Institute on Drug Abuse. Medicago is eligible for milestones. InterveXion Therapeutics LLC...
Items per page:
1 - 2 of 2
BioCentury | Nov 12, 2009
Distillery Therapeutics

Indication: Neurology

...2009 Multiple patent applications filed and two patents issued; all patents and applications licensed by InterveXion Therapeutics LLC...
BioCentury | Jun 13, 2005
Company News

InterveXion, Medicago deal

...to produce clinical supplies of a monoclonal antibody from InterveXion to treat phencyclidine (PCP) addiction. InterveXion...
...million grant from the NIH's National Institute on Drug Abuse. Medicago is eligible for milestones. InterveXion Therapeutics LLC...
Items per page:
1 - 2 of 2